EP0291916A1 — Dithioacetal compounds, processes for preparation thereof and pharmaceutical composition comprising the same
Assigned to Fujisawa Pharmaceutical Co Ltd · Expires 1988-11-23 · 37y expired
What this patent protects
A dithioacetal compound of the formula : wherein R¹ is lower alkyl, di-(lower)alkylamino, aryl, or heterocyclic group which may have one or more substituents selected from halogen, lower alkyl, lower alkoxy and phenyl, R² and R³ are each lower alkyl, aryl or ar-(lower)alk…
USPTO Abstract
A dithioacetal compound of the formula : wherein R¹ is lower alkyl, di-(lower)alkylamino, aryl, or heterocyclic group which may have one or more substituents selected from halogen, lower alkyl, lower alkoxy and phenyl, R² and R³ are each lower alkyl, aryl or ar-(lower)alkyl, or R² and R³ are together to form 1,3-dithian ring, R⁴ is hydrogen or lower alkoxy, and n is O or an integer 1 to 4 and pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising them as an active ingredient.
Drugs covered by this patent
- Oxbryta (voxelotor) · Global Blood Theraps
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.